RARA CRAFT DATABASE for FDA Medical Devices
510(k)K150791

FDA DEVICE FACTS

Healgen Secobarbital Test(Strip, Cassette, Cup, Dip Card), Healgen Burprenorphine Test (Strip, Cassette, Cup, Dip Card), Healgen Methadone Test (Strip, Cassette, Cup, Dip Card)

Healgen Scientific,, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 24, 2015PRODUCT CODEDIS

Indications for use

Healgen Secobarbital Test is an immunochromatogr aphic assay for the qualitative determination of Secobarbital in human urine at a Cut-Off concentra tion of 300 ng/mL. The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format. The test may yield preliminary positive results even when the prescription drug Secobarbital is ingested, at prescribed doses; it is not intended to distinguish between prescription use or abuse of this drug. There is no uniformly recognized cutoff concentration level for Secobarbital in urine. The test provides only preliminary test results. A more speci fic alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferre d confirmatory method. Clin ical consideration and professional judgment should be exerci sed with any drug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-the-counter use. Healgen Buprenorphine Test is an immunochromatographic assay for the qualitative determination of Buprenorphine in human urine at a Cut-Off concentration of 10 ng/mL. Th e test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format. The test may yield preliminary positive results ev en when the prescription drug Buprenorphine is ingested, at prescribed doses; it is not intended to distinguish between prescrip tion use or abuse of this drug. There is no uniformly recognized cutoff concentra tion level for Buprenorphine in urine. The test provides only preliminary test resu lts. A more specific alternative ch emical method must be used in order to obtain a confirmed analy tical result. GC/MS is the prefe rred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-the-counter use. Healgen Methadone Test is an immunochromatographi c assay for the qualitative determination of Methadone in human urine at a Cut-Off concentrati on of 300 ng/mL. The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format. The test provides only preliminary test results. A more specific alte rnative chemical method must be used in order to obtain a confirmed analytical re sult. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment shoul d be exercised with any dr ug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-the-counter use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 6, 2026